In this regard, it was recently shown that a chemical activator of p53 in combination with an antibody that targets PS on tumor blood vessels and disrupts tumor vasculature effectively inhibits metastasis of p53-expressing TNBC cells to the lungs in a mouse model (44). The gene discussed is TP53; the disease is neoplasm.